SCHEMBL29199014

SCHEMBL29199014

O=C(Nc1ncsn1)c1cccnc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.56
HIF1A Q16665 1/20 0.56
ROCK2 O75116 1/20 0.55
ROCK1 Q13464 1/20 0.55
AQP4 P55087 1/20 0.55
HDAC1 Q13547 2/20 0.53
HDAC6 Q9UBN7 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
ALDH1A1 P00352 2/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
KDM4E B2RXH2 1/20 0.50
HDAC3 O15379 1/20 0.50
HDAC2 Q92769 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
KCNK3 O14649 1/20 0.50
HTT P42858 1/20 0.50
HPGD P15428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25381348 0.81 GAA (0.53) LMNASMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL6643666 0.81 LMNA (0.67) LMNAHIF1AROCK2ROCK1HDAC1
SCHEMBL11591966 0.79 LMNA (0.69) LMNAHIF1AROCK2ROCK1AQP4
SCHEMBL11591993 0.78 LMNA (0.63) LMNAHIF1AROCK2ROCK1AQP4
SCHEMBL25383099 0.74 NPC1 (0.53) LMNAHDAC1HDAC6SMN1; SMN2NPC1
SCHEMBL11591085 0.73 HDAC1 (0.60) LMNAHIF1AROCK2ROCK1HDAC1
SCHEMBL11591466 0.73 HDAC1 (0.60) LMNAHIF1AROCK2ROCK1HDAC1
SCHEMBL7553959 0.73 AQP4 (0.61) LMNAHIF1AROCK2ROCK1AQP4
SCHEMBL1571386 0.73 LMNA (1.00) LMNAHIF1AROCK2ROCK1NPC1
SCHEMBL23015840 0.72 TDP1 (0.56) LMNAHIF1AROCK2ROCK1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118159536-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-06-07 CN claimed
CN-117794928-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-03-29 CN claimed
US-20240352010-A1 SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2024-10-24 US disclosed
EP-4387970-A1 SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES Bayer Aktiengesellschaft (DE) 2024-06-26 EP disclosed
CN-118159536-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-06-07 CN disclosed
CN-118159536-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-06-07 CN disclosed
CN-118159536-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-06-07 CN disclosed
CN-117794928-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-03-29 CN disclosed
CN-117794928-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-03-29 CN disclosed
CN-117794928-A Substituted 1,2, 4-thiadiazolyl nicotinamide, salts or N-oxides thereof and their use as herbicidal active substances 拜耳公司 2024-03-29 CN disclosed
WO-2023020964-A1 SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES BAYER AKTIENGESELLSCHAFT (DE) 2023-02-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240352010-A1 SUBSTITUTED 1,2,4-THIADIAZOLYL NICOTINAMIDES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES NQO1, NNMT, NADK LMNA 3539/4885HIF1A 2098/4885ROCK2 3738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.